Researchers in the Peterson lab utilize high-throughout screening technologies to discover new drug candidates for cardiovascular, nervous system, and metabolic disorders. Unlike conventional drug discovery programs that utilize simplified, in vitro assays, the Peterson lab screens using living zebrafish, ensuring that the drug candidates discovered are active in vivo. Several compounds discovered in the lab have not only become widely used research tools, but also preclinical drug candidates.
Randall T. Peterson, PhD
Randy received his PhD from Harvard University after studying as a Howard Hughes Medical Institute predoctoral fellow in the laboratory of Professor Stuart L. Schreiber. Following graduation, he completed a postdoctoral fellowship with Professor Mark Fishman at Massachusetts General Hospital. Dr. Peterson then went on to spend 14 years as a faculty member at Harvard University, where he was an Associate Professor of Medicine at Harvard Medical School, an Associate Biologist at Massachusetts General Hospital, and a Senior Associate Member of the Broad Institute. In January of 2017, he arrived at the University of Utah as L.S. Skaggs Presidential Endowed Professor and Dean of the College of Pharmacy.